Hyperoside inhibits EHV-8 infection via alleviating oxidative stress and IFN production through activating JNK/Keap1/Nrf2/HO-1 signaling pathways
Journal of Virology · 16.04.2024 · 98 (4)
DOI: 10.1128/jvi.00159-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, erschienen am 16.04.2024. Verfasst von Tongtong Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Agronomy, Liaocheng University, Liaocheng, China. Hauptthemen laut MEDLINE: Antiviral Agents, Herpesviridae Infections, Herpesvirus 1, Equid, MAP Kinase Signaling System. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), | Natural Science Foundation of Shandong Province (), 山东省科学技术厅 | Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Equine herpesvirus type 8 (EHV-8) causes abortion and respiratory disease in horses and donkeys, leading to serious economic losses in the global equine industry. Currently, there is no effective vaccine or drug against EHV-8 infection, underscoring the need for a novel antiviral drug to prevent EHV-8-induced latent infection and decrease the pathogenicity of this virus. The present study demonstrated that hyperoside can exert antiviral effects against EHV-8 infection in RK-13 (rabbit kidney cells), MDBK (Madin–Darby bovine kidney), and NBL-6 cells (E. Derm cells). Mechanistic investigations revealed that hyperoside induces heme oxygenase-1 expression by activating the c-Jun N-terminal kinase/nuclear factor erythroid-2-related factor 2/Kelch-like ECH-associated protein 1 axis, alleviating oxidative stress and triggering a downstream antiviral interferon response. Accordingly, hyperoside inhibits EHV-8 infection. Meanwhile, hyperoside can also mitigate EHV-8-induced injury in the lungs of infected mice. These results indicate that hyperoside may serve as a novel antiviral agent against EHV-8 infection. IMPORTANCE Hyperoside has been reported to suppress viral infections, including herpesvirus, hepatitis B virus, infectious bronchitis virus, and severe acute respiratory syndrome coronavirus 2 infection. However, its mechanism of action against equine herpesvirus type 8 (EHV-8) is currently unknown. Here, we demonstrated that hyperoside significantly inhibits EHV-8 adsorption and internalization in susceptible cells. This process induces HO-1 expression via c-Jun N-terminal kinase/nuclear factor erythroid-2-related factor 2/Kelch-like ECH-associated protein 1 axis activation, alleviating oxidative stress and triggering an antiviral interferon response. These findings indicate that hyperoside could be very effective as a drug against EHV-8.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Agronomy, Liaocheng University, Liaocheng, China.
- College of Veterinary Medicine, Qingdao Agricultural University, Qingdao, China.
ORCID-Profile: Yubao Li, Changfa Wang, Liangliang Li
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- | Natural Science Foundation of Shandong Province ()
- 山东省科学技术厅 | Natural Science Foundation of Shandong Province
Zitieren
APA
Wang, T., Hu, L., Li, R., Ren, H., Li, S., Sun, Q., Ding, X., Li, Y., Wang, C., & Li, L. (2024). Hyperoside inhibits EHV-8 infection via alleviating oxidative stress and IFN production through activating JNK/Keap1/Nrf2/HO-1 signaling pathways. Journal of Virology, 98(4). https://doi.org/10.1128/jvi.00159-24
Vancouver
Wang T, Hu L, Li R, Ren H, Li S, Sun Q, et al. Hyperoside inhibits EHV-8 infection via alleviating oxidative stress and IFN production through activating JNK/Keap1/Nrf2/HO-1 signaling pathways. Journal of Virology. 2024;98(4). doi:10.1128/jvi.00159-24
BibTeX
@article{Wang2024,
author = {Wang, Tongtong and Hu, Leyu and Li, Ruibo and Ren, Huiying and Li, Shuwen and Sun, Qi and Ding, Xiangdan and Li, Yubao and Wang, Changfa and Li, Liangliang},
title = {Hyperoside inhibits EHV-8 infection via alleviating oxidative stress and IFN production through activating JNK/Keap1/Nrf2/HO-1 signaling pathways},
journal = {Journal of Virology},
year = {2024},
volume = {98},
number = {4},
doi = {10.1128/jvi.00159-24}
}
EUVIMED